Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas

Identification of biomarkers to recognize individuals with Barrett's esophagus (BE) predisposed to develop malignancy is currently a pressing issue. We utilized gene expression profiling to compare molecular signatures of normal esophagus and stomach, BE, and adenocarcinoma (AC) to identify su...

Full description

Bibliographic Details
Main Authors: Charles A. Fox, Lisa M. Sapinoso, Hong Zhang, Wanghai Zhang, Howard L. McLeod, Gina R. Petroni, Tarun Mullick, Christopher A. Moskaluk, Henry F. Frierson, Garret M. Hampton, Steven M. Powell
Format: Article
Language:English
Published: Elsevier 2005-04-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558605800727
id doaj-5403deea7e904aeaa8eafff5a39a4e53
record_format Article
spelling doaj-5403deea7e904aeaa8eafff5a39a4e532020-11-25T00:36:36ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022005-04-017440741610.1593/neo.04715Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated AdenocarcinomasCharles A. Fox0Lisa M. Sapinoso1Hong Zhang2Wanghai Zhang3Howard L. McLeod4Gina R. Petroni5Tarun Mullick6Christopher A. Moskaluk7Henry F. Frierson8Garret M. Hampton9Steven M. Powell10Digestive Health Center of Excellence, Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USAGenomics Institute of the Novartis Research Foundation, San Diego, CA, USADepartment of Pathology, Anhui Medical University, Hefei, Anhui, ChinaDepartment of Medicine, Molecular Biology, Pharmacology, and Genetics, Washington University, St. Louis, MO, USADepartment of Medicine, Molecular Biology, Pharmacology, and Genetics, Washington University, St. Louis, MO, USAHealth Evaluation Sciences, University of Virginia, Charlottesville, VA, USADigestive Health Center of Excellence, Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USADepartment of Pathology, University of Virginia, Charlottesville, VA, USADepartment of Pathology, University of Virginia, Charlottesville, VA, USAGenomics Institute of the Novartis Research Foundation, San Diego, CA, USADigestive Health Center of Excellence, Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USA Identification of biomarkers to recognize individuals with Barrett's esophagus (BE) predisposed to develop malignancy is currently a pressing issue. We utilized gene expression profiling to compare molecular signatures of normal esophagus and stomach, BE, and adenocarcinoma (AC) to identify such potential biomarkers. Over 22,000 genes were analyzed by oligonucleotide microarrays on 38 unique RNA. Unsupervised and supervised clusterings were performed on a subset of 2849 genes that varied most significantly across the specimens. Unsupervised clustering identified two discernable molecular BE profiles, one of which was similar to normal gastric tissue (“BE1”), and another that was shared by several of the AC specimens (“BE2”). The BE1 profile included expression of several genes that have been described as tumor-suppressor genes, most notably trefoil factor 1 (TFF-1). The BE2 profile included expression of genes previously found overexpressed in cancers, such as carboxylesterase-2 (CES-2). IHC demonstrated the loss of TFF-1 late in the progression of BE to AC. It also revealed CES-2 as being upregulated in AC documented to have arisen in the presence of BE. These potential biomarkers, as well as the relative expression of genes from BE1 versus those from BE2, may be validated in the future to aid in risk stratification and guide treatment protocols in patients with BE and associated AC. http://www.sciencedirect.com/science/article/pii/S1476558605800727Trefoil Factor 1Carboxylesterase 2Barrett's esophagusesophageal or gastric adenocarcinomatissue microarry
collection DOAJ
language English
format Article
sources DOAJ
author Charles A. Fox
Lisa M. Sapinoso
Hong Zhang
Wanghai Zhang
Howard L. McLeod
Gina R. Petroni
Tarun Mullick
Christopher A. Moskaluk
Henry F. Frierson
Garret M. Hampton
Steven M. Powell
spellingShingle Charles A. Fox
Lisa M. Sapinoso
Hong Zhang
Wanghai Zhang
Howard L. McLeod
Gina R. Petroni
Tarun Mullick
Christopher A. Moskaluk
Henry F. Frierson
Garret M. Hampton
Steven M. Powell
Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas
Neoplasia: An International Journal for Oncology Research
Trefoil Factor 1
Carboxylesterase 2
Barrett's esophagus
esophageal or gastric adenocarcinoma
tissue microarry
author_facet Charles A. Fox
Lisa M. Sapinoso
Hong Zhang
Wanghai Zhang
Howard L. McLeod
Gina R. Petroni
Tarun Mullick
Christopher A. Moskaluk
Henry F. Frierson
Garret M. Hampton
Steven M. Powell
author_sort Charles A. Fox
title Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas
title_short Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas
title_full Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas
title_fullStr Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas
title_full_unstemmed Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas
title_sort altered expression of tff-1 and ces-2 in barrett's esophagus and associated adenocarcinomas
publisher Elsevier
series Neoplasia: An International Journal for Oncology Research
issn 1476-5586
1522-8002
publishDate 2005-04-01
description Identification of biomarkers to recognize individuals with Barrett's esophagus (BE) predisposed to develop malignancy is currently a pressing issue. We utilized gene expression profiling to compare molecular signatures of normal esophagus and stomach, BE, and adenocarcinoma (AC) to identify such potential biomarkers. Over 22,000 genes were analyzed by oligonucleotide microarrays on 38 unique RNA. Unsupervised and supervised clusterings were performed on a subset of 2849 genes that varied most significantly across the specimens. Unsupervised clustering identified two discernable molecular BE profiles, one of which was similar to normal gastric tissue (“BE1”), and another that was shared by several of the AC specimens (“BE2”). The BE1 profile included expression of several genes that have been described as tumor-suppressor genes, most notably trefoil factor 1 (TFF-1). The BE2 profile included expression of genes previously found overexpressed in cancers, such as carboxylesterase-2 (CES-2). IHC demonstrated the loss of TFF-1 late in the progression of BE to AC. It also revealed CES-2 as being upregulated in AC documented to have arisen in the presence of BE. These potential biomarkers, as well as the relative expression of genes from BE1 versus those from BE2, may be validated in the future to aid in risk stratification and guide treatment protocols in patients with BE and associated AC.
topic Trefoil Factor 1
Carboxylesterase 2
Barrett's esophagus
esophageal or gastric adenocarcinoma
tissue microarry
url http://www.sciencedirect.com/science/article/pii/S1476558605800727
work_keys_str_mv AT charlesafox alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas
AT lisamsapinoso alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas
AT hongzhang alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas
AT wanghaizhang alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas
AT howardlmcleod alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas
AT ginarpetroni alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas
AT tarunmullick alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas
AT christopheramoskaluk alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas
AT henryffrierson alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas
AT garretmhampton alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas
AT stevenmpowell alteredexpressionoftff1andces2inbarrettsesophagusandassociatedadenocarcinomas
_version_ 1725304584617852928